PCSK9 Inhibitors

Nisha K. Patel, PharmD, MBA, BCPS, Saira Khan, M.D., Alona Crowder, Pharm.D.



To be used as an adjunct to diet and maximally tolerated statin therapy in:

  • Adult patients with heterozygous familial hypercholesterolemia
  • Adult patients with homozygous familial hypercholesterolemia
  • Patients with clinical atherosclerotic cardiovascular disease who require additional LDL lowering

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 4, 2020